GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Development of ureadepsipetides for drug-resistant infections

$1,529,042
Michael Lafleur · Arietis · R01 · FY2019 · AI

PItt-Ohio State-Georgetown Clinical Trials Unit

$1,528,540
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2018 · AI

Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples

$1,528,228
Sadanand Gite · First Light Diagnostics , Inc. · R01 · FY2015 · AI

Host Defense Against HIV-related Pulmonary Infections

$1,528,062
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2006 · HL

Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease

$1,527,723
Steven J. Schiff · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · AI

Nanohybrid Composites Minimize Antibiotic Resistant Infections

$1,526,832
Bingyun Li · West Virginia University · R01 · FY2025 · AI

Host Defense Against HIV-related Pulmonary Infections

$1,526,515
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2007 · HL

Centers for Research on Structural Biology of Infectious Diseases: Antibacterial Resistance Research Activities

$1,526,050
Karla Satchell · Northwestern University At Chicago · N01 · FY2024 · AI

Medication Development for the Treatment of Alcohol Use Disorder

$1,521,805
Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2020 · AA

Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART

$1,521,130
Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2014 · AI

Host Defense Against HIV-related Pulmonary Infections

$1,521,038
Louisiana State Univ Hsc New Orleans · P01 · FY2005 · HL

Small RNAs as Novel Modulators of Microbe-Host Interactions

$1,505,179
Zemer Gitai · Princeton University · R01 · FY2021 · AT

Small RNAs as Novel Modulators of Microbe-Host Interactions

$1,505,179
Zemer Gitai · Princeton University · R01 · FY2024 · AT

Small RNAs as Novel Modulators of Microbe-Host Interactions

$1,505,179
Zemer Gitai · Princeton University · R01 · FY2022 · AT

Small RNAs as Novel Modulators of Microbe-Host Interactions

$1,505,179
Zemer Gitai · Princeton University · R01 · FY2025 · AT

Small RNAs as Novel Modulators of Microbe-Host Interactions

$1,505,179
Zemer Gitai · Princeton University · R01 · FY2023 · AT

Bioinformatics Tools and Services at NLM for AMR

$1,500,000
Kathryn Freeland · · N02 · FY2022 · LM

Genetic Variations and Development of Vesicoureteral Reflux and Sequelae

$1,500,000
David Sullivan Hains · Research Inst Nationwide Children'S Hosp · RC4 · FY2010 · DK

Horizontal Gene Transfer at Landscape Scale in Microbial Communities Under Selection For Antimicrobial Resistance

$1,500,000
James J Morris · University Of Alabama At Birmingham · · FY2025 · BIO

Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection

$1,500,000
Tor C. Savidge · Baylor College Of Medicine · U01 · FY2016 · AI

Innovative Oral Formulations for Anti-Tb Drugs

$1,499,796
Luna Innovations, Inc. · N01 · FY2018 · AI

Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions

$1,499,265
Susan S Huang · University Of California-Irvine · UH3 · FY2015 · AI

Innovative technologies to transform antibiotic discovery. Project 3 Rapid Access to Antibiotic Biosynthesis Machinery Using Synthetic Biology

$1,496,521
Robert Nicol · Broad Institute, Inc. · U19 · FY2022 · AI

Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections

$1,495,694
Michael E Selsted · University Of Southern California · R01 · FY2016 · AI

Discovery, Design, and Development of Phosphonic Acid Antibiotics

$1,495,534
William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2016 · GM